Title: Influence of Family Dynamics on Medication Adherence among Hypertensive Patients in a Tertiary Hospital in South-West Nigeria
Authors: Olusegun Emmanuel Gabriel, Oluwaserimi Adewumi Ajetunmobi, Olabode Muftau Shabi, Adebara Idowu Oluwaseyi, Olusegun Adesola Busari., Ayokunle Samuel Dada
DOI: https://dx.doi.org/10.18535/jmscr/v5i7.138
Abstract
INTRODUCTION
Hypertension is an overwhelming global challenge estimated to cause 7.5 million death, which is about 12.8% of all deaths.1 The emerging pandemic of non-communicable diseases (NCDs) is creating major health challenges worldwide. Of the 56 million global deaths in 2012, 38 million (68%) were attributed to NCDs, with almost three quarters (74%) of these deaths occurring in low and middle income countries.2 Indeed, it is estimated that up to three-quarters of the world's hypertensive population will be in economically developing countries by the year 2025.3,4 Nigeria, like most other developing countries is undergoing epidemiological transition and faces the double burden of communicable and non-communicable diseases.3,4 Of the latter, hypertension is one of the most important treatable causes of morbidity and mortality.3.
References
1. WHO (2014) Global status report on non communicable diseases 2014 Geneva: World Health Organization.
2. Ekwunife OI, Aguwa CN. A meta analysis of prevalence rate of hypertension in Nigerian populations. Journal of Public Health and epidemiology. 2011 Dec 31;3(13):604-7.
3. Chiazor IE, Oparah AC. Assessment of hypertension care in a Nigerian Hospital. Tropical Journal of Pharmaceutical Research. 2012 Feb 1;11(1):137-45.
4. Ambaw AD, Alemie GA, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC public health. 2012 Apr 10;12(1):1.
5. Sheilini MM, George A, Pai MS, Sanatombi E. Antihypertensive treatment, medication Non- Adherence and factors leading to Non-Adherence among elderly. Medical Science. 2014 Aug; 3 (8).
6. Goyal R, Sarwate N. A correlative study of hypertension with lipid profile. Int J Res Appl Natural Soc Sci. 2014;2:143-50.
7. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, Stewart S, Sliwa K. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World journal of cardiology. 2012 Dec 26;4(12):327.
8. Boima V, Ademola AD, Odusola AO, Agyekum F, Nwafor CE, Cole H, Salako BL, Ogedegbe G, Tayo BO. Factors Associated with Medication Nonadherence among Hypertensives in Ghana and Nigeria. International journal of hypertension. 2015 Oct 5;2015.
9. Busari OA, Olanrewaju TO, Desalu OO, Opadijo OG, Jimoh AK, Agboola SM, Busari OE, Olalekan O. Impact of patients’ knowledge, attitude and practices on hypertension on compliance with antihypertensive drugs in a resource-poor setting. TAF Preventive Medicine Bulletin. 2010;9(2):87-92.
10. Campell TL, Bray JH. The family’s influence on health. In: Rakel RE, editor. Text book of family practice. 6th ed. Philadelphia London. New york. WB Saunder 2001; 34-40.
11. Berge JM, Wall M, Larson N, Loth KA, Neumark-Sztainer D. Family functioning: associations with weight status, eating behaviors, and physical activity in adolescents. Journal of adolescent health. 2013 Mar 31;52(3):351-7.
12. Osamor PE, Owumi BE. Factors associated with treatment compliance in hypertension in southwest Nigeria. Journal of Health, Population and Nutrition. 2011 Dec 1:619-28.
13. Morisky DE, Ang A, Krousel‐Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension 2008 May 1;10(5):348-54.
14. Procidiano ME, Heller K. Measures of perceived social support from friends and family: Three validation studies. American Journal of Community Psychology 1983; 11: 1- 24.
15. Lam WY, Fresco P. Medication adherence measures: an overview. BioMed Res Int. 2015 Jan
1;2015:217047.
16. Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PloS one. 2013 Apr 25;8(4):e62775.
17. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. Jama. 2010 May 26;303(20):2043-50.
18. Schiffrin EL. Hypertension: treatments, diabetes, and developing regions. The Lancet. 2012 Aug 11;380(9841):539-41.
19. Ikechuwku EO, Obinna UP, Ogochukwu AM. Predictors of Self Reported Adherence to Antihypertensive Drugs in a Nigerian Population. International Journal of Pharmaceutical Sciences. 2012;2:23-9.
20. Ibrahim MM, Damasceno A. Hypertension in developing countries. The Lancet. 2012 Aug 17;380(9841):611-9.
21. Karaeren H, Yokuşoğlu M, Uzun S, Baysan O, Köz C, Kara B, et al. The effect of the content of the knowledge on adherence to medication in hypertensive patients. Ana do lu Kar di yol Derg. 2009;9(3):183-8.
22. Daniel AC, Veiga EV. Factors that interfere the medication compliance in hypertensive patients. Einstein (sao paulo). 2013 Sep;11(3):331-7.
23. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004; 164: 722-732.
24. Hussanin SM, Boonshuyar C, Ekram AR. Non-adherence to antihypertensive treatment in essential hypertensive patients in Rajshahi, Bangladesh. Anwer Khan Modern Medical College Journal. 2011;2(1):9-14.
25. Alsolami F, Hou XY, Correa-Velez I. Factors affecting antihypertensive treatment adherence: a Saudi Arabian perspective. Clinical Medicine and Diagnostics. 2012;2(4):27-32.
26. Afolabi BA, Afolabi MO, Afolabi AA, Odewale MA, Olowookere SA. Roles of family dynamics on adherence to highly active antiretroviral therapy among people living with HIV/AIDS at a tertiary hospital in Osogbo, south-west Nigeria. African health sciences. 2013 Dec 1;13(4):920-6.
27. Tabasi HK, Madarshahian F, Nikoo MK, Hassanabadi M, Mahmoudirad G. Impact of family support improvement behaviors on anti diabetic medication adherence and cognition in type 2 diabetic patients. Journal of Diabetes & Metabolic Disorders. 2014 Nov 25;13(1):1.
Olusegun Emmanuel Gabriel
Department of Family Medicine,
Federal Teaching Hospital Ido Ekiti, Ekiti state Nigeria
Email: This email address is being protected from spambots. You need JavaScript enabled to view it., 08068886933